| Year |
Citation |
Score |
| 2020 |
Alexander KL, Serrano CA, Chakraborty A, Nearing M, Council LN, Riquelme A, Garrido M, Bellis SL, Smythies LE, Smith PD. Modulation of glycosyltransferase ST6Gal-I in gastric cancer-derived organoids disrupts homeostatic epithelial cell turnover. The Journal of Biological Chemistry. PMID 32763973 DOI: 10.1074/Jbc.Ra120.014887 |
0.35 |
|
| 2020 |
Alexander KL, Nearing M, Chakraborty A, Bellis S, Smythies LE, Smith PD, Peter S. Sa1210 ST6GAL-I IS UPREGULATED IN BARRETT'S ESOPHAGUS STEM CELLS AND DYSPLASIA Gastroenterology. 158: S-313. DOI: 10.1016/S0016-5085(20)31482-7 |
0.325 |
|
| 2019 |
Pensa NW, Curry AS, Bonvallet PP, Bellis NF, Rettig KM, Reddy MS, Eberhardt AW, Bellis SL. 3D printed mesh reinforcements enhance the mechanical properties of electrospun scaffolds. Biomaterials Research. 23: 22. PMID 31798944 DOI: 10.1186/S40824-019-0171-0 |
0.307 |
|
| 2019 |
Dorsett KA, Jones RB, Ankenbauer KE, Hjelmeland AB, Bellis SL. Sox2 promotes expression of the ST6Gal-I glycosyltransferase in ovarian cancer cells. Journal of Ovarian Research. 12: 93. PMID 31610800 DOI: 10.1186/S13048-019-0574-5 |
0.359 |
|
| 2019 |
Pensa NW, Curry AS, Reddy MS, Bellis SL. Sustained delivery of the angiogenic QK peptide through the use of polyglutamate domains to control peptide release from bone graft materials. Journal of Biomedical Materials Research. Part A. PMID 31408258 DOI: 10.1002/Jbm.A.36779 |
0.386 |
|
| 2019 |
Curry AS, McPherson DT, Barlow AM, Pensa NW, Reddy MS, Bellis SL. Addition of an oligoglutamate domain to bone morphogenic protein 2 confers binding to hydroxyapatite materials and induces osteoblastic signaling. Plos One. 14: e0217766. PMID 31150531 DOI: 10.1371/Journal.Pone.0217766 |
0.386 |
|
| 2019 |
Zhang Q, Higginbotham JN, Jeppesen DK, Yang YP, Li W, McKinley ET, Graves-Deal R, Ping J, Britain CM, Dorsett KA, Hartman CL, Ford DA, Allen RM, Vickers KC, Liu Q, ... ... Bellis SL, et al. Transfer of Functional Cargo in Exomeres. Cell Reports. PMID 30956133 DOI: 10.1016/J.Celrep.2019.01.009 |
0.308 |
|
| 2019 |
Pensa NW, Curry AS, Reddy MS, Bellis SL. The addition of a polyglutamate domain to the angiogenic QK peptide improves peptide coupling to bone graft materials leading to enhanced endothelial cell activation. Plos One. 14: e0213592. PMID 30856221 DOI: 10.1371/Journal.Pone.0213592 |
0.409 |
|
| 2019 |
Dorsett KA, Bellis SL. Abstract TMIM-071: SOX2 DRIVES ST6GAL-I EXPRESSION AND ACTIVITY TO PROMOTE A CSC PHENOTYPE IN OVARIAN CANCER Clinical Cancer Research. 25. DOI: 10.1158/1557-3265.Ovcasymp18-Tmim-071 |
0.353 |
|
| 2018 |
Shin B, Kress RL, Kramer PA, Darley-Usmar VM, Bellis SL, Harrington LE. Effector CD4 T cells with progenitor potential mediate chronic intestinal inflammation. The Journal of Experimental Medicine. PMID 29915024 DOI: 10.1084/Jem.20172335 |
0.308 |
|
| 2018 |
Jones RB, Dorsett KA, Hjelmeland AB, Bellis SL. The ST6Gal-I sialyltransferase protects tumor cells against hypoxia by enhancing HIF-1α signaling. The Journal of Biological Chemistry. PMID 29475939 DOI: 10.1074/Jbc.Ra117.001194 |
0.351 |
|
| 2018 |
Britain CM, Holdbrooks AT, Anderson JC, Willey CD, Bellis SL. Sialylation of EGFR by the ST6Gal-I sialyltransferase promotes EGFR activation and resistance to gefitinib-mediated cell death. Journal of Ovarian Research. 11: 12. PMID 29402301 DOI: 10.1186/S13048-018-0385-0 |
0.346 |
|
| 2018 |
Chakraborty A, Jones RB, Klug CA, Smythies LE, Bellis SL. Abstract 4092: Glycosyltransferase ST6Gal-I promotes pancreatic ductal adenocarcinoma progression and metastasis Cancer Research. 78: 4092-4092. DOI: 10.1158/1538-7445.Am2018-4092 |
0.375 |
|
| 2018 |
Britain C, Holdbrooks A, Bellis S. Abstract 2504: Sialylation of EGFR by the glycosyltransferase ST6Gal-I results in receptor activation and resistance to gefitinib mediated apoptosis Cancer Research. 78: 2504-2504. DOI: 10.1158/1538-7445.Am2018-2504 |
0.355 |
|
| 2018 |
Jones RB, Dorsett KA, Hjelmeland AB, Bellis SL. Abstract 2435: ST6Gal-I sialylation potentiates hypoxia adaptation by enhancing HIF-1a signaling Cancer Research. 78: 2435-2435. DOI: 10.1158/1538-7445.Am2018-2435 |
0.369 |
|
| 2018 |
Holdbrooks AT, Schultz MJ, Liu Z, Bullard DC, Bellis SL. Abstract 2334: Sialylation of the TNFR1 death receptor promotes cancer cell survival Cancer Research. 78: 2334-2334. DOI: 10.1158/1538-7445.Am2018-2334 |
0.394 |
|
| 2018 |
Dorsett KA, Bellis SL. Abstract 1129: Sox2 drives ST6Gal-I expression and activity to promote a CSC phenotype in ovarian cancer Cancer Research. 78: 1129-1129. DOI: 10.1158/1538-7445.Am2018-1129 |
0.343 |
|
| 2018 |
Alexander KL, Chakraborty A, Serrano C, Shin B, Musgrove L, Bellis S, Smith PD, Smythies LE. 716 - Glycosyltransferase ST6GAL-I Associates with WNT Signaling Molecules and is a Characteristic Marker of Mucosal Epithelial Stem Cells Gastroenterology. 154: S-148-S-149. DOI: 10.1016/S0016-5085(18)30912-0 |
0.337 |
|
| 2017 |
Holdbrooks AT, Britain CM, Bellis SL. ST6Gal-I sialyltransferase promotes tumor necrosis factor (TNF)-mediated cancer cell survival via sialylation of the TNF receptor 1 (TNFR1) death receptor. The Journal of Biological Chemistry. PMID 29233887 DOI: 10.1074/Jbc.M117.801480 |
0.368 |
|
| 2017 |
Chakraborty A, Dorsett KA, Trummell HQ, Yang ES, Oliver PG, Bonner JA, Buchsbaum DJ, Bellis SL. ST6Gal-I sialyltransferase promotes chemoresistance in pancreatic ductal adenocarcinoma by abrogating gemcitabine-mediated DNA damage. The Journal of Biological Chemistry. PMID 29191829 DOI: 10.1074/Jbc.M117.808584 |
0.347 |
|
| 2017 |
Britain CM, Dorsett KA, Bellis SL. Glycosyltransferase ST6Gal-I protects tumor cells against serum growth factor withdrawal by enhancing survival signaling and proliferative potential. The Journal of Biological Chemistry. PMID 28154177 DOI: 10.1074/Jbc.M116.763862 |
0.379 |
|
| 2016 |
Schultz MJ, Holdbrooks AT, Chakraborty A, Grizzle WE, Landen CN, Buchsbaum DJ, Conner MB, Arend RC, Yoon KJ, Klug C, Bullard DC, Kesterson RA, Oliver PG, O'Connor AK, Yoder BK, ... Bellis SL, et al. The tumor-associated glycosyltransferase ST6Gal-I regulates stem cell transcription factors and confers a cancer stem cell phenotype. Cancer Research. PMID 27216178 DOI: 10.1158/0008-5472.Can-15-2834 |
0.354 |
|
| 2016 |
Curry AS, Pensa NW, Barlow AM, Bellis SL. Taking cues from the extracellular matrix to design bone-mimetic regenerative scaffolds. Matrix Biology : Journal of the International Society For Matrix Biology. PMID 26940231 DOI: 10.1016/J.Matbio.2016.02.011 |
0.369 |
|
| 2016 |
Britain C, Bellis S. Abstract 4402: Glycosyltransferase ST6Gal-I enables cancer cells to survive upon growth factor deprivation Cancer Research. 76: 4402-4402. DOI: 10.1158/1538-7445.Am2016-4402 |
0.386 |
|
| 2016 |
Holdbrooks A, Schultz MJ, Liu Z, Bullard D, Bellis SL. Abstract 3566: Glycosylation of the TNFR1 death receptor controls cell fate Cancer Research. 76: 3566-3566. DOI: 10.1158/1538-7445.Am2016-3566 |
0.39 |
|
| 2016 |
Dorsett KA, Bellis SL. Abstract 3336: ST6Gal-I glycosyltransferase promotes an undifferentiated cell phenotype and enhances c-kit signaling Cancer Research. 76: 3336-3336. DOI: 10.1158/1538-7445.Am2016-3336 |
0.428 |
|
| 2016 |
Schultz MJ, Holdbrooks AT, Chakraborty A, Grizzle WE, Landen CN, Buchsbaum DJ, Conner MG, Arend RC, Yoon KJ, Klug CA, Bullard DC, Kesterson RA, Oliver PG, O’Connor AK, Yoder BK, ... Bellis SL, et al. Abstract 3327: The tumor associated sialyltransferase ST6Gal-I promotes a cancer stem cell phenotype and upregulates stem-related transcription factors Cancer Research. 76: 3327-3327. DOI: 10.1158/1538-7445.Am2016-3327 |
0.35 |
|
| 2016 |
Chakraborty A, Schultz M, Trummell HQ, Bonner JA, Bellis S. Abstract 2114: Glycosyltransferase ST6Gal-I protects against chemotherapy induced DNA damage and subsequent apoptosis in pancreatic adenocarcinoma cells Cancer Research. 76: 2114-2114. DOI: 10.1158/1538-7445.Am2016-2114 |
0.348 |
|
| 2015 |
Bain JL, Bonvallet PP, Abou-Arraj RV, Schupbach P, Reddy MS, Bellis SL. Enhancement of the Regenerative Potential of Anorganic Bovine Bone Graft Utilizing a Polyglutamate-Modified BMP2 Peptide with Improved Binding to Calcium-Containing Materials. Tissue Engineering. Part A. 21: 2426-36. PMID 26176902 DOI: 10.1089/ten.TEA.2015.0160 |
0.698 |
|
| 2015 |
Bonvallet PP, Schultz MJ, Mitchell EH, Bain JL, Culpepper BK, Thomas SJ, Bellis SL. Microporous dermal-mimetic electrospun scaffolds pre-seeded with fibroblasts promote tissue regeneration in full-thickness skin wounds. Plos One. 10: e0122359. PMID 25793720 DOI: 10.1371/Journal.Pone.0122359 |
0.786 |
|
| 2014 |
Bain JL, Culpepper BK, Reddy MS, Bellis SL. Comparing variable-length polyglutamate domains to anchor an osteoinductive collagen-mimetic peptide to diverse bone grafting materials. The International Journal of Oral & Maxillofacial Implants. 29: 1437-45. PMID 25397807 DOI: 10.11607/Jomi.3759 |
0.793 |
|
| 2014 |
Bonvallet PP, Culpepper BK, Bain JL, Schultz MJ, Thomas SJ, Bellis SL. Microporous dermal-like electrospun scaffolds promote accelerated skin regeneration. Tissue Engineering. Part A. 20: 2434-45. PMID 24568584 DOI: 10.1089/Ten.Tea.2013.0645 |
0.788 |
|
| 2014 |
Culpepper BK, Webb WM, Bonvallet PP, Bellis SL. Tunable delivery of bioactive peptides from hydroxyapatite biomaterials and allograft bone using variable-length polyglutamate domains Journal of Biomedical Materials Research - Part A. 102: 1008-1016. PMID 23625466 DOI: 10.1002/Jbm.A.34766 |
0.803 |
|
| 2013 |
Zheng Y, McFarland BC, Drygin D, Yu H, Bellis SL, Kim H, Bredel M, Benveniste EN. Targeting protein kinase CK2 suppresses prosurvival signaling pathways and growth of glioblastoma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 19: 6484-94. PMID 24036851 DOI: 10.1158/1078-0432.Ccr-13-0265 |
0.304 |
|
| 2013 |
Schultz MJ, Swindall AF, Wright JW, Sztul ES, Landen CN, Bellis SL. ST6Gal-I sialyltransferase confers cisplatin resistance in ovarian tumor cells. Journal of Ovarian Research. 6: 25. PMID 23578204 DOI: 10.1186/1757-2215-6-25 |
0.791 |
|
| 2013 |
Swindall AF, Londoño-Joshi AI, Schultz MJ, Fineberg N, Buchsbaum DJ, Bellis SL. ST6Gal-I protein expression is upregulated in human epithelial tumors and correlates with stem cell markers in normal tissues and colon cancer cell lines. Cancer Research. 73: 2368-78. PMID 23358684 DOI: 10.1158/0008-5472.Can-12-3424 |
0.805 |
|
| 2013 |
Culpepper BK, Morris DS, Prevelige PE, Bellis SL. Engineering nanocages with polyglutamate domains for coupling to hydroxyapatite biomaterials and allograft bone. Biomaterials. 34: 2455-62. PMID 23312905 DOI: 10.1016/J.Biomaterials.2012.12.026 |
0.805 |
|
| 2013 |
Culpepper BK, Bonvallet PP, Reddy MS, Ponnazhagan S, Bellis SL. Polyglutamate directed coupling of bioactive peptides for the delivery of osteoinductive signals on allograft bone. Biomaterials. 34: 1506-13. PMID 23182349 DOI: 10.1016/J.Biomaterials.2012.10.046 |
0.802 |
|
| 2013 |
Schultz MJ, Liu Z, Landen CN, Bellis SL. Abstract A78: Control of tumor cell survival mechanisms by a novel glycan-modifying enzyme Clinical Cancer Research. 19. DOI: 10.1158/1078-0432.Ovca13-A78 |
0.373 |
|
| 2012 |
Phipps MC, Xu Y, Bellis SL. Delivery of platelet-derived growth factor as a chemotactic factor for mesenchymal stem cells by bone-mimetic electrospun scaffolds. Plos One. 7: e40831. PMID 22808271 DOI: 10.1371/Journal.Pone.0040831 |
0.791 |
|
| 2012 |
Schultz MJ, Swindall AF, Bellis SL. Regulation of the metastatic cell phenotype by sialylated glycans. Cancer Metastasis Reviews. 31: 501-18. PMID 22699311 DOI: 10.1007/S10555-012-9359-7 |
0.809 |
|
| 2012 |
Phipps MC, Clem WC, Grunda JM, Clines GA, Bellis SL. Increasing the pore sizes of bone-mimetic electrospun scaffolds comprised of polycaprolactone, collagen I and hydroxyapatite to enhance cell infiltration. Biomaterials. 33: 524-34. PMID 22014462 DOI: 10.1016/J.Biomaterials.2011.09.080 |
0.8 |
|
| 2012 |
Schultz MJ, Swindall AF, Bellis SL. Abstract 4899: Altered receptor glycosylation confers cisplatin resistance in ovarian and colon cancer cells Cancer Research. 72: 4899-4899. DOI: 10.1158/1538-7445.Am2012-4899 |
0.795 |
|
| 2012 |
Swindall AF, Liu Z, Bellis SL. Abstract 245: ST6Gal-I sialylation of the Fas (CD95) receptor provides protection against Fas mediated apoptosis Cancer Research. 72: 245-245. DOI: 10.1158/1538-7445.Am2012-245 |
0.795 |
|
| 2012 |
Schnaar R, Paulson JC, Macauley MS, Nycholat C, Pfrengle F, Rademacher C, Mahan A, Dionne K, Suscovich T, Alter G, Katoh T, Kiwamoto T, Brummet M, Bochner B, Tiemeyer M, ... ... Bellis SL, ... ... Bellis S, et al. Program and abstracts for the 2012 Joint Meeting of the Society for Glycobiology & American Society for Matrix Biology Glycobiology. 22: 1518-1650. DOI: 10.1093/Glycob/Cws127 |
0.788 |
|
| 2011 |
Liu Z, Swindall AF, Kesterson RA, Schoeb TR, Bullard DC, Bellis SL. ST6Gal-I regulates macrophage apoptosis via α2-6 sialylation of the TNFR1 death receptor. The Journal of Biological Chemistry. 286: 39654-62. PMID 21930713 DOI: 10.1074/Jbc.M111.276063 |
0.787 |
|
| 2011 |
Swindall AF, Bellis SL. Sialylation of the Fas death receptor by ST6Gal-I provides protection against Fas-mediated apoptosis in colon carcinoma cells. The Journal of Biological Chemistry. 286: 22982-90. PMID 21550977 DOI: 10.1074/Jbc.M110.211375 |
0.778 |
|
| 2011 |
Bellis SL. Advantages of RGD peptides for directing cell association with biomaterials. Biomaterials. 32: 4205-10. PMID 21515168 DOI: 10.1016/J.Biomaterials.2011.02.029 |
0.412 |
|
| 2011 |
Zhang X, Xu Y, Thomas V, Bellis SL, Vohra YK. Engineering an antiplatelet adhesion layer on an electrospun scaffold using porcine endothelial progenitor cells. Journal of Biomedical Materials Research. Part A. 97: 145-51. PMID 21370444 DOI: 10.1002/Jbm.A.33040 |
0.338 |
|
| 2011 |
Phipps MC, Clem WC, Catledge SA, Xu Y, Hennessy KM, Thomas V, Jablonsky MJ, Chowdhury S, Stanishevsky AV, Vohra YK, Bellis SL. Mesenchymal stem cell responses to bone-mimetic electrospun matrices composed of polycaprolactone, collagen I and nanoparticulate hydroxyapatite. Plos One. 6: e16813. PMID 21346817 DOI: 10.1371/Journal.Pone.0016813 |
0.814 |
|
| 2011 |
Zhuo Y, Bellis SL. Emerging role of alpha2,6-sialic acid as a negative regulator of galectin binding and function. The Journal of Biological Chemistry. 286: 5935-41. PMID 21173156 DOI: 10.1074/Jbc.R110.191429 |
0.41 |
|
| 2011 |
Deshpande H, Schindler C, Dean D, Clem W, Bellis SL, Nyairo E, Mishra M, Thomas V. Nanocomposite scaffolds based on electrospun polycaprolactone/modified CNF/nanohydroxyapatite by electrophoretic deposition Journal of Biomaterials and Tissue Engineering. 1: 177-184. DOI: 10.1166/Jbt.2011.1024 |
0.757 |
|
| 2010 |
Culpepper BK, Phipps MC, Bonvallet PP, Bellis SL. Enhancement of peptide coupling to hydroxyapatite and implant osseointegration through collagen mimetic peptide modified with a polyglutamate domain. Biomaterials. 31: 9586-94. PMID 21035181 DOI: 10.1016/J.Biomaterials.2010.08.020 |
0.808 |
|
| 2010 |
Zhang X, Thomas V, Xu Y, Bellis SL, Vohra YK. An in vitro regenerated functional human endothelium on a nanofibrous electrospun scaffold. Biomaterials. 31: 4376-81. PMID 20199808 DOI: 10.1016/J.Biomaterials.2010.02.017 |
0.328 |
|
| 2010 |
Jose MV, Thomas V, Xu Y, Bellis S, Nyairo E, Dean D. Aligned bioactive multi-component nanofibrous nanocomposite scaffolds for bone tissue engineering. Macromolecular Bioscience. 10: 433-44. PMID 20112236 DOI: 10.1002/Mabi.200900287 |
0.402 |
|
| 2009 |
Anderson JM, Kushwaha M, Tambralli A, Bellis SL, Camata RP, Jun HW. Osteogenic differentiation of human mesenchymal stem cells directed by extracellular matrix-mimicking ligands in a biomimetic self-assembled peptide amphiphile nanomatrix. Biomacromolecules. 10: 2935-44. PMID 19746964 DOI: 10.1021/Bm9007452 |
0.443 |
|
| 2009 |
Hennessy KM, Pollot BE, Clem WC, Phipps MC, Sawyer AA, Culpepper BK, Bellis SL. The effect of collagen I mimetic peptides on mesenchymal stem cell adhesion and differentiation, and on bone formation at hydroxyapatite surfaces. Biomaterials. 30: 1898-909. PMID 19157536 DOI: 10.1016/J.Biomaterials.2008.12.053 |
0.799 |
|
| 2008 |
Christie DR, Shaikh FM, Lucas JA, Lucas JA, Bellis SL. ST6Gal-I expression in ovarian cancer cells promotes an invasive phenotype by altering integrin glycosylation and function. Journal of Ovarian Research. 1: 3. PMID 19014651 DOI: 10.1186/1757-2215-1-3 |
0.703 |
|
| 2008 |
Shaikh FM, Seales EC, Clem WC, Hennessy KM, Zhuo Y, Bellis SL. Tumor cell migration and invasion are regulated by expression of variant integrin glycoforms. Experimental Cell Research. 314: 2941-50. PMID 18703050 DOI: 10.1016/J.Yexcr.2008.07.021 |
0.786 |
|
| 2008 |
Zhuo Y, Chammas R, Bellis SL. Sialylation of beta1 integrins blocks cell adhesion to galectin-3 and protects cells against galectin-3-induced apoptosis. The Journal of Biological Chemistry. 283: 22177-85. PMID 18676377 DOI: 10.1074/Jbc.M8000015200 |
0.414 |
|
| 2008 |
Woodard-Grice AV, McBrayer AC, Wakefield JK, Zhuo Y, Bellis SL. Proteolytic shedding of ST6Gal-I by BACE1 regulates the glycosylation and function of alpha4beta1 integrins. The Journal of Biological Chemistry. 283: 26364-73. PMID 18650447 DOI: 10.1074/Jbc.M800836200 |
0.801 |
|
| 2008 |
Vohra S, Hennessy KM, Sawyer AA, Zhuo Y, Bellis SL. Comparison of mesenchymal stem cell and osteosarcoma cell adhesion to hydroxyapatite. Journal of Materials Science. Materials in Medicine. 19: 3567-74. PMID 18626747 DOI: 10.1007/S10856-008-3525-Z |
0.827 |
|
| 2008 |
Liu Y, Pan D, Bellis SL, Song Y. Effect of altered glycosylation on the structure of the I-like domain of beta1 integrin: a molecular dynamics study. Proteins. 73: 989-1000. PMID 18536010 DOI: 10.1002/Prot.22126 |
0.359 |
|
| 2008 |
Clem WC, Chowdhury S, Catledge SA, Weimer JJ, Shaikh FM, Hennessy KM, Konovalov VV, Hill MR, Waterfeld A, Bellis SL, Vohra YK. Mesenchymal stem cell interaction with ultra-smooth nanostructured diamond for wear-resistant orthopaedic implants. Biomaterials. 29: 3461-8. PMID 18490051 DOI: 10.1016/J.Biomaterials.2008.04.045 |
0.805 |
|
| 2008 |
Hennessy KM, Clem WC, Phipps MC, Sawyer AA, Shaikh FM, Bellis SL. The effect of RGD peptides on osseointegration of hydroxyapatite biomaterials. Biomaterials. 29: 3075-83. PMID 18440064 DOI: 10.1016/J.Biomaterials.2008.04.014 |
0.791 |
|
| 2008 |
Rennolds J, Boyaka PN, Bellis SL, Cormet-Boyaka E. Low temperature induces the delivery of mature and immature CFTR to the plasma membrane. Biochemical and Biophysical Research Communications. 366: 1025-9. PMID 18096515 DOI: 10.1016/J.Bbrc.2007.12.065 |
0.317 |
|
| 2008 |
Woodard-Grice AV, McBrayer A, Bellis S. Hyposialylation regulates alpha4beta1 integrin binding to VCAM-1 The Faseb Journal. 22: 443-443. DOI: 10.1096/Fasebj.22.2_Supplement.443 |
0.767 |
|
| 2008 |
Kim H, Camata RP, Hennessy KM, Bellis SL, Lee S, Rohrer GS, Rollett AD, Vohra YK. Microstructure, mechanical properties, and bioactivity in calcium phosphates with controlled crystallographic texture 8th World Biomaterials Congress 2008. 2: 573. |
0.71 |
|
| 2007 |
Bei L, Lu Y, Bellis SL, Zhou W, Horvath E, Eklund EA. Identification of a HoxA10 activation domain necessary for transcription of the gene encoding beta3 integrin during myeloid differentiation. The Journal of Biological Chemistry. 282: 16846-59. PMID 17439948 DOI: 10.1074/Jbc.M609744200 |
0.347 |
|
| 2007 |
Sawyer AA, Hennessy KM, Bellis SL. The effect of adsorbed serum proteins, RGD and proteoglycan-binding peptides on the adhesion of mesenchymal stem cells to hydroxyapatite. Biomaterials. 28: 383-92. PMID 16952395 DOI: 10.1016/J.Biomaterials.2006.08.031 |
0.812 |
|
| 2006 |
Advincula MC, Rahemtulla FG, Advincula RC, Ada ET, Lemons JE, Bellis SL. Osteoblast adhesion and matrix mineralization on sol-gel-derived titanium oxide. Biomaterials. 27: 2201-12. PMID 16313951 DOI: 10.1016/J.Biomaterials.2005.11.014 |
0.382 |
|
| 2006 |
Clem WC, Konovalov VV, Chowdhury S, Vohra YK, Catledge SA, Bellis SL. Mesenchymal stem cell adhesion and spreading on microwave plasma-nitrided titanium alloy. Journal of Biomedical Materials Research. Part A. 76: 279-87. PMID 16265649 DOI: 10.1002/Jbm.A.30557 |
0.774 |
|
| 2006 |
Kim H, Camata RP, Lee S, Rohrer GS, Rollett AD, Hennessy KM, Bellis SL, Vohra YK. Calcium phosphate bioceramics with tailored crystallographic texture for controlling cell adhesion Materials Research Society Symposium Proceedings. 925: 7-12. DOI: 10.1557/Proc-0925-Bb02-07 |
0.753 |
|
| 2006 |
WOODARDGRICE A, MCBRAYER A, BELLIS S. Hyposialylation of β1 integrins activates α4β1 receptors Matrix Biology. 25: S50-S51. DOI: 10.1016/J.Matbio.2006.08.140 |
0.759 |
|
| 2006 |
Hennessy KM, Bellis SL. RGD peptides inhibit osseointegration of hydroxyapatite implants Matrix Biology. 25. DOI: 10.1016/J.Matbio.2006.08.025 |
0.32 |
|
| 2005 |
Seales EC, Shaikh FM, Woodard-Grice AV, Aggarwal P, McBrayer AC, Hennessy KM, Bellis SL. A protein kinase C/Ras/ERK signaling pathway activates myeloid fibronectin receptors by altering beta1 integrin sialylation. The Journal of Biological Chemistry. 280: 37610-5. PMID 16157583 DOI: 10.1074/Jbc.M508476200 |
0.764 |
|
| 2005 |
Sawyer AA, Weeks DM, Kelpke SS, McCracken MS, Bellis SL. The effect of the addition of a polyglutamate motif to RGD on peptide tethering to hydroxyapatite and the promotion of mesenchymal stem cell adhesion. Biomaterials. 26: 7046-56. PMID 15964067 DOI: 10.1016/J.Biomaterials.2005.05.006 |
0.812 |
|
| 2005 |
Seales EC, Jurado GA, Brunson BA, Wakefield JK, Frost AR, Bellis SL. Hypersialylation of beta1 integrins, observed in colon adenocarcinoma, may contribute to cancer progression by up-regulating cell motility. Cancer Research. 65: 4645-52. PMID 15930282 DOI: 10.1158/0008-5472.Can-04-3117 |
0.802 |
|
| 2005 |
Sawyer AA, Hennessy KM, Bellis SL. Regulation of mesenchymal stem cell attachment and spreading on hydroxyapatite by RGD peptides and adsorbed serum proteins. Biomaterials. 26: 1467-75. PMID 15522748 DOI: 10.1016/J.Biomaterials.2004.05.008 |
0.821 |
|
| 2005 |
Kilpadi KL, Sawyer AA, Prince CW, Chang PL, Bellis SL. Erratum: Primary human marrow stromal cells and Saos-2 osteosarcoma cells use different mechanisms to adhere to hydroxylapatite (Journal of Biomedical Materials Research - Part A (2004) 68A, 2 (273-285) DOI: 10.1002/jbm.a.20043) Journal of Biomedical Materials Research Part A. 73. DOI: 10.1002/Jbm.A.30290 |
0.777 |
|
| 2004 |
Catledge SA, Vohra YK, Bellis SL, Sawyer AA. Mesenchymal stem cell adhesion and spreading on nanostructured biomaterials. Journal of Nanoscience and Nanotechnology. 4: 986-9. PMID 15656191 DOI: 10.1166/Jnn.2004.137 |
0.799 |
|
| 2004 |
Bellis SL. Variant glycosylation: an underappreciated regulatory mechanism for beta1 integrins. Biochimica Et Biophysica Acta. 1663: 52-60. PMID 15157607 DOI: 10.1016/J.Bbamem.2004.03.012 |
0.368 |
|
| 2004 |
Kilpadi KL, Sawyer AA, Prince CW, Chang PL, Bellis SL. Primary human marrow stromal cells and Saos-2 osteosarcoma cells use different mechanisms to adhere to hydroxylapatite. Journal of Biomedical Materials Research. Part A. 68: 273-85. PMID 14704969 DOI: 10.1002/Jbm.A.20043 |
0.821 |
|
| 2003 |
Seales EC, Jurado GA, Singhal A, Bellis SL. Ras oncogene directs expression of a differentially sialylated, functionally altered beta1 integrin. Oncogene. 22: 7137-45. PMID 14562042 DOI: 10.1038/Sj.Onc.1206834 |
0.803 |
|
| 2002 |
Semel AC, Seales EC, Singhal A, Eklund EA, Colley KJ, Bellis SL. Hyposialylation of integrins stimulates the activity of myeloid fibronectin receptors. The Journal of Biological Chemistry. 277: 32830-6. PMID 12091385 DOI: 10.1074/Jbc.M202493200 |
0.812 |
|
| 2001 |
Han X, Stewart JE, Bellis SL, Benveniste EN, Ding Q, Tachibana K, Grammer JR, Gladson CL. TGF-beta1 up-regulates paxillin protein expression in malignant astrocytoma cells: requirement for a fibronectin substrate. Oncogene. 20: 7976-86. PMID 11753680 DOI: 10.1038/Sj.Onc.1204996 |
0.43 |
|
| 2001 |
Kilpadi KL, Chang PL, Bellis SL. Hydroxylapatite binds more serum proteins, purified integrins, and osteoblast precursor cells than titanium or steel. Journal of Biomedical Materials Research. 57: 258-67. PMID 11484189 DOI: 10.1002/1097-4636(200111)57:2<258::Aid-Jbm1166>3.0.Co;2-R |
0.832 |
|
| 1999 |
Bellis SL, Newman E, Friedman EA. Steps in integrin beta1-chain glycosylation mediated by TGFbeta1 signaling through Ras. Journal of Cellular Physiology. 181: 33-44. PMID 10457351 DOI: 10.1002/(Sici)1097-4652(199910)181:1<33::Aid-Jcp4>3.0.Co;2-# |
0.409 |
|
| 1997 |
Bellis SL, Perrotta JA, Curtis MS, Turner CE. Adhesion of fibroblasts to fibronectin stimulates both serine and tyrosine phosphorylation of paxillin Biochemical Journal. 325: 375-381. PMID 9230116 DOI: 10.1042/Bj3250375 |
0.308 |
|
| 1995 |
Bellis SL, Miller JT, Turner CE. Characterization of tyrosine phosphorylation of paxillin in vitro by focal adhesion kinase Journal of Biological Chemistry. 270: 17437-17441. PMID 7615549 DOI: 10.1074/Jbc.270.29.17437 |
0.322 |
|
| 1994 |
Bellis SL, Laux DC, Rhoads DE. Affinity purification of Hydra glutathione binding proteins Febs Letters. 354: 320-324. PMID 7957948 DOI: 10.1016/0014-5793(94)01154-0 |
0.319 |
|
| Show low-probability matches. |